» Articles » PMID: 8625118

Distal Spread of Rectal Cancer and Optimal Distal Margin of Resection for Sphincter-preserving Surgery

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1995 Aug 1
PMID 8625118
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ascertaining the optimal distal margin of resection in sphincter-preserving surgery has become an important problem. This study was designed to examine distal rectal spread of rectal carcinoma and to determine the optimal distal margin of resection for sphincter-preserving surgery.

Methods: Six hundred ten consecutive specimens of resected rectal carcinomas were analyzed retrospectively and pathologically.

Results: Sixty-one patients (10%) had distal spread. In patients who underwent curative surgery, distal spread was observed in only 3.8% (19/505). Distal spread was not found in patients with Stage I disease (0/150), according to the International Union Against Cancer stage. Only 1.2% (2/162) of patients with Stage II disease and 5.1% (10/195) with Stage III disease had slight spread but this was confined within a 1 cm length. Most patients with distal spread had a lower survival rate and died of distant metastasis rather than local recurrence, even after curative surgery.

Conclusions: Distal spread seems to be an important risk factor for distant metastasis. Distal margin of resection of 1 cm may be appropriate clearance for most rectal cancers.

Citing Articles

Current Management of Locally Recurrent Rectal Cancer.

Coco C, Rizzo G, Amodio L, Pafundi D, Marzi F, Tondolo V Cancers (Basel). 2024; 16(23).

PMID: 39682094 PMC: 11640487. DOI: 10.3390/cancers16233906.


Determining the optimal distal resection margin in rectal cancer patients by imaging of large pathological sections: An experimental study.

Lin S, Wei J, Lai H, Zhu Y, Gong H, Wei C Medicine (Baltimore). 2024; 103(21):e38083.

PMID: 38787988 PMC: 11124751. DOI: 10.1097/MD.0000000000038083.


Comparison of long-term quality of life based on surgical procedure in patients with rectal cancer.

Yuge K, Miwa K, Fujita F, Murotani K, Shigaki T, Yoshida N Front Oncol. 2023; 13:1197131.

PMID: 37274255 PMC: 10235785. DOI: 10.3389/fonc.2023.1197131.


Impact of Microscopically Positive (≤1 mm) Distal Margins on Disease Recurrence in Rectal Cancer Treated by Neoadjuvant Chemoradiotherapy.

Sorrentino L, Sileo A, Daveri E, Battaglia L, Guaglio M, Centonze G Cancers (Basel). 2023; 15(6).

PMID: 36980714 PMC: 10047023. DOI: 10.3390/cancers15061828.


Single-center comparative study of short-term outcomes of transanal and laparoscopic total mesorectal excisions for low and middle rectal cancers.

Adachi T, Kitaguchi D, Teramura K, Hasegawa H, Ikeda K, Tsukada Y Surg Endosc. 2023; 37(6):4698-4706.

PMID: 36890411 DOI: 10.1007/s00464-023-09948-1.